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ABSTRACT
Aims: Research objectively evaluating physical activity 
(PA) and sleep in adults with hypermobile Ehlers–
Danlos syndrome (hEDS) and generalized hypermobility 
spectrum disorder (G-HSD) is lacking. Furthermore, it is 
not clear to what extent frequently occurring symptoms in 
these patients are related to their PA and sleep. Therefore, 
a cross-sectional study was performed to objectively 
evaluate, and identify factors contributing to, PA and sleep 
in adults with hEDS and G-HSD.
Methods: Twenty female adults with hEDS, 23 
with G-HSD, and 32 healthy controls participated. 
Physical activity and sleep were measured using two 
tri-axial ActiGraphs worn over seven consecutive days. 
Furthermore, questionnaires evaluating frequently 
occurring symptoms were completed. Regression analysis 
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was performed to determine major contributors to PA and 
sleep.
Results: Daily step counts were significantly lower in 
both patient groups compared to the control (CTR) group 
(p<0.04) and to the recommended 7500 steps (p≤0.001). 
Other PA and sleep variables did not differ between 
the groups. In the hEDS group, body mass index and 
kinesiophobia were related to PA, explaining 53% of the 
variance in step counts. In the G-HSD group, 18.5% of the 
variance in step counts could be attributed to the variance 
in pain impact.
Conclusion: Adults with hEDS and G-HSD had lower 
step counts than healthy peers, which may be partially due 
to kinesiophobia and the impact of pain respectively. No 
differences in objectively measured sleep parameters were 
identified. Treatment focusing on fear-avoidance beliefs 
and pain relief could potentially increase daily step counts 
and benefit overall health in these patients.
Keywords: Hypermobile Ehlers–Danlos syndrome, Hy-
permobility spectrum disorder, Physical activity, Sleep
How to cite this article
Coussens M, De Wandele I, Pacey V, Malfait F, De 
Craemer M, Demeyer H, Rombaut L, Calders P. 
Physical activity and sleep in patients with hypermobile 
Ehlers–Danlos syndrome and patients with generalized 






Edorium Journal of Disability and Rehabilitation, Vol. 6; 2020. ISSN: 2456-8392
Edorium J Disabil Rehabil 2020;6:100049D05MC2020.  
www.edoriumjournals.com/ej/dr
Coussens et al. 2
INTRODUCTION
Ehlers–Danlos syndrome (EDS) is a hereditary 
connective tissue disease caused by mutations in genes 
encoding for fibrillary collagens or their modifiers, 
resulting in hypermobility, tissue fragility, and skin 
hyper extensibility [1, 2]. Previously, six subtypes were 
distinguished based on the Villefranche criteria of 1997 
[1]. Since the identification of numerous mutations in an 
array of novel genes, the EDS classification was revised in 
2017, now covering 13 subtypes of which the hypermobile 
type of EDS (hEDS) is the most common [2]. However, 
as the genetic basis of hEDS remains unknown, diagnosis 
is based on clinical criteria, which include generalized 
joint hypermobility (GJH) and chronic pain, as well 
as signs of soft tissue fragility such as organ prolapse, 
atrophic scarring, aortic root dilatation, mild skin 
hyperextensibility, and multiple abdominal hernias [2]. 
Patients with joint hypermobility not meeting the criteria 
for hEDS are currently diagnosed with hypermobility 
spectrum disorder (HSD), of which the generalized 
subtype (G-HSD) is characterized by GJH with secondary 
musculoskeletal symptoms. These symptoms include 
musculoskeletal or soft tissue traumas, chronic pain, 
reduced proprioception and muscle strength, and other 
musculoskeletal traits caused by the interaction between 
the affected musculoskeletal tissues and mechanical 
forces [3].
Joint instability, recurrent joint dislocations, poor 
proprioception, reduced muscle strength, and fear of 
movement have been postulated as potential causes for 
reduced physical activity, which is a common feature in 
patients with GJH [4–7]. Besides a lower habitual PA and 
sport activities level, poor PA levels were identified with 
50% of the patients with GJH being inactive [5, 8–10]. In 
turn, reduced physical activity may lead to impaired sleep 
quality in hEDS/HSD, as these are bidirectionally related in 
the general population [11–13]. Moreover, impaired sleep 
quality has been observed in patients with symptomatic 
GJH, reflected as a higher prevalence of obstructive sleep 
apnea and snoring, problems of maintaining sleep and 
not feeling refreshed in the morning [14, 15]. Gaisl et al. 
(2017) have shown that these sleeping problems have a 
major impact on their health-related quality of life [16]. 
Furthermore, frequently occurring symptoms such as 
pain and fatigue compromise sleep and PA, resulting in a 
vicious circle of activity limitations and impaired quality 
of life [5, 7–9, 17–20].
There is overwhelming evidence of the health benefits 
of regular PA and good sleep quality in healthy individuals 
and patient populations, such as a reduced mortality and 
reduced incidence of several chronic medical conditions 
(e.g., cardiovascular diseases, hypertension, and several 
cancers) [21–23]. However, studies measuring PA and 
sleep in a hypermobile and EDS population are scarce 
and mainly based on self-report questionnaires, which 
are known to likely result in misclassification due to 
participants providing socially desirable responses. 
Furthermore, previous reports included patients with 
generalized hypermobility diagnosed according to the 
older and less strict diagnostic criteria [1]. Moreover, it 
is not clear to what extent frequently occurring features 
such as fatigue, pain, anxiety, and depression are related 
to PA and sleep in these patient populations. Therefore, 
this study aims to objectively evaluate PA and sleep (using 
tri-axial accelerometry) of adults with hEDS and G-HSD 
diagnosed according to the new diagnostic criteria, and 
compare this to the PA and sleep of healthy controls and 
recommended values. The major contributors to PA levels 
and sleep quality of individuals with hEDS and G-HSD 
will also be examined. We hypothesize that, based on the 
clinical profile of both patient groups, PA and sleep are 
impaired in comparison with the healthy controls and 
associated with typical features such as pain and fatigue.
MATERIALS AND METHODS
Participants
This study protocol was reviewed and approved by 
the Ethical Committee of Ghent University Hospital (EC 
number 2017/1311), and written informed consent was 
obtained from all participants. Recruitment and data 
collection were performed between November 2017 and 
March 2019. Twenty female individuals with hEDS and 
23 with G-HSD, aged between 18 and 65 years, were 
recruited from the Center for Medical Genetics of Ghent 
University Hospital. Exclusion criteria were pregnancy, 
recent surgery of the lower extremity, and any current 
neurologic or orthopedic conditions unrelated to hEDS/
G-HSD affecting balance or gait. Furthermore, 32 female 
healthy controls individually matched to both patient 
groups for age (± 3 years) and body mass index (BMI; ± 
2 kg/m2) were recruited through social media and flyers. 
They were included in this study, if they—in addition 
to the exclusion criteria for the patient groups—did not 
have GJH, measured by a Beighton score of 5/9 or more 
in adults <50 years old and 4/9 or more in adults ≥50 
years old. The Beighton score is a reliable screening tool 
consisting of nine tests, of which age-dependent cut-off 
scores (as above) indicate generalized joint hypermobility 
[1, 24].
Procedure
Participants were invited by e-mail or phone to 
participate in this study at Ghent University Hospital. 
Participant characteristics, including hypermobility 
(Beighton score), BMI, height (digital scale), weight 
(stadiometer), profession, current working status, 
education, marital status, and age (questionnaires) 
were evaluated. All participants were enrolled in the 
study for one week in autumn or winter to control for 
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seasonal effects on PA [25]. During this week (i.e., 7 days) 
participants were asked to complete questionnaires every 
evening to evaluate their pain, analgesic medication, 
sleepiness, mood, and fatigue, while also wearing tri-axial 
accelerometers to measure their sleep and PA. At the end 
of the test week, surveys evaluating quality of life (QoL), 
kinesiophobia, and the psychosocial impact of pain were 
completed.
Physical activity and sleep measure-
ments
Physical activity and sleep were measured using two tri-
axial ActiGraphGT3X-BT accelerometers (ActiGraphTM, 
LLC, Pensacola, FL, USA). One ActiGraph was worn on 
the right hip (midaxillary line at the level of the iliac crest) 
to measure PA, a procedure previously shown to be valid 
[26]. The other ActiGraph was worn on the dominant 
wrist to score sleep. This has previously been shown to 
have high sensitivity, moderate specificity, and overall 
high accuracy [27, 28]. Participants were instructed to 
wear these directly on the skin 24 hours a day during 
seven consecutive days, except for water-based activities 
[29].
Data were recorded at a frequency of 90 Hz, as these 
sampling frequencies produce more accurate estimates 
[29]. Data were only included in the PA analysis if 
four or more valid days with ≥ 8 hours of wearing time 
during waking hours (i.e., 7:00 AM–10:00 PM) was 
achieved [30]. Non-wear time was defined as 60 minutes 
of consecutive zero counts per minute (cpm), without 
interruptions in counts [31]. For sleep analysis, reported 
bedtime (‘when did you try to go to sleep?’) and wake time 
(‘when did you wake up?’) of each participant was used to 
identify sleep periods. Participants were included in sleep 
analysis when having at least four nights of sleep data. 
Epoch lengths (1 s for PA and 60 s for sleep analysis), 
cut-points and algorithms of PA and sleep were based on 
previously published validation studies [32, 33].
Daily step count was retrieved as main PA outcome. 
As secondary PA outcomes, PA was categorized in four 
categories based on intensity: daily minutes spent 
in moderate (vector magnitude = 2690–6166 cpm), 
vigorous (vector magnitude = 6167–9642 cpm), very 
vigorous (vector magnitude ≥ 9643 cpm) and, combining 
moderate, vigorous and very vigorous activity minutes 
together, moderate to vigorous physical intensity 
(MVPA) [32]. The following sleep parameters (during 
the night) were determined: total sleep time (min), total 
bed time (min), sleep efficiency (main sleep outcome as 
the percentage of total sleep time divided by total bed 
time), wake after sleep onset (WASO, amount of time in 
minutes awake after sleep commenced and before final 
awakening), latency (time in minutes from bedtime to 
first sleep bout), and overall number of awakenings [33]. 
All parameters were analyzed with ActiLife 6 software. 
For each participant, the mean of these parameters on all 
valid days (PA) or nights (sleep) was calculated.
Patient-reported outcomes
All participants were asked to complete a series of 
questionnaires. The outcomes that were reported by the 
participants and used in analyses are shown in Table 1 
[34–50]. Six questionnaires were completed on a daily 
basis, of which the mean of all days was calculated and 
included in the analysis. Three questionnaires were filled 
in at the end of the week and results on weekly basis were 
included in analysis.
Table 1: Patient-reported outcomes






Margolis pain diagram 
(34)
Daily Color painful body 
areas on a diagram
Total scores: 0–100% 
Higher scores: larger 












Daily / Higher scores: higher 
number of doses pain 







Daily Eight questions about 
the chances of falling 
asleep in different 
situations, ranging from 
0 (no chance of dozing) 
to 3 (high chance of 
dozing)
Total score: 0 (no 
daytime sleepiness) to 
24 (excessive daytime 
sleepiness)
Moderate validity and 
high IC (α=0.88) in 
patients with sleep 
disorders (37,38)
Edorium Journal of Disability and Rehabilitation, Vol. 6; 2020. ISSN: 2456-8392
Edorium J Disabil Rehabil 2020;6:100049D05MC2020.  
www.edoriumjournals.com/ej/dr
Coussens et al. 4







questions: (1) ‘how 
well did you sleep last 
night?’, (2) ‘How often 
did you wake up last 
night?’ and (3) ‘How 
well recovered did you 
feel on waking this 
morning?’
Daily Three questions 
ranging from 0 to 6:
(1) 0 = excellent, 6 = 
very poorly
(2) 0 = not once, 6 = 
a lot
(3) 0 = completely, 6 = 
not at all
Total score: 0 





Hospital Anxiety and 
Depression Scale 
(HADS) (39)
Daily Seven questions about 
anxiety and seven about 
depression, ranging 
from 0 to 3
Anxiety: 0–21
Depression: 0–21
Higher scores: more 
affective distress
High IC (mean α 
for anxiety: 0.83, 
α for depression: 
0.82), moderate 
to high validity in 
patients with anxiety/
depression (40)
Fatigue Checklist Individual 
Strength (CIS) (41, 42)
Daily 20 questions, four 
subscales: subjective 
fatigue, reduction in 
motivation, in activity 
and in concentration
Total CIS score 
(summation of all 
subscales): 20–140
Higher scores: higher 
degree of fatigue, 
impaired motivation, 




to high validity in 
healthy people, cancer 





RAND 36-item Health 
Survey (SF36) (44)
End of the 
week
Eight domains: (1) 
physical functioning, 
(2) bodily pain, (3) 
role limitations due 
to physical problems, 
(4) general health 
perception, (5) social 
functioning, (6) general 
mental health, (7) 
vitality, and (8) role 
limitations due to 
emotional problems. 
Raw scales were 
linearly converted to a 
0 to 100 scale
Physical (PCS; domain 
1–4) and mental (MCS; 
domain 5–8) health 
component summary 
score: 0–400
Higher scores: higher 
levels of well-being or 
functioning
High IC (Mean α 
across scales = 0.84), 
moderate to high 
validity in healthy 
population, migraine 




and fear of 
(re)injury
TAMPA scale for 
Kinesiophobia (TSK) 
(45,46)
End of the 
week
17 questions, ranging 
from 1 (strongly 
disagree) to 4 (strongly 
agree)
Total score: 17–68
Higher scores: higher 
degree of kinesiophobia
Acceptable to good 
IC (α=0.79-0.81) in 
patients with chronic 
low back pain/FM, 
moderate validity in 
patients with acute 





End of the 
week
Only part one (pain-
relevant psychosocial 
aspects) was included. 
Five subscales: pain 
severity, interference 
with the daily life due 
to pain, perceived life 




mean scores on each 
subscale): 0-30
Higher scores: higher 
psychosocial impact of 
pain
Acceptable to good 
IC (α=0.74–0.89) in 
patients with FM/
back pain, good 
validity in patients 
with chronic pain 
(49,50)
r: correlation coefficient, α: Cronbach’s alpha, CFS: chronic fatigue syndrome, FM: fibromyalgia, IC: internal consistency.
Table 1: (Continued)
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Statistical analyses
Data analysis was performed using the statistical 
package SPSS version 25. Missing data (<8% for all 
outcomes) were excluded from analysis. Normality was 
evaluated by the Shapiro–Wilk test and visual inspection 
of the Q-Q plots. Data are shown as mean ± SD (normal 
distribution) or medians and quartiles. Parametric 
univariate analysis of variance (ANOVA) analyses were 
performed to compare questionnaire outcomes and 
PA and sleep outcomes between the three groups. For 
all variables, statistical assumptions for the univariate 
ANOVA analysis were fulfilled, except for total sleep time 
and checklist individual strength (CIS) in which a Welch 
ANOVA was performed. When significant differences 
were identified, a post-hoc Tukey test was performed. 
Other continuous data (non-normally distributed) were 
compared between the three groups (hEDS, G-HSD, and 
CTR group) by a non-parametric Kruskall Wallis test, 
after which a pairwise comparison was performed (Dunn–
Bonferroni) if significant differences were observed. 
Categorical parameters were compared between groups 
by a Fisher exact test. Additionally, a one-sample T test 
was performed to compare daily PA (step count) and 
sleep (sleep efficiency) parameters with recommended 
values (7500 steps or “somewhat active” and 85% 
sleep efficiency respectively) [51, 52]. Furthermore, 
absolute and relative frequencies were calculated of the 
participants (not) meeting these recommended values.
To identify the relationship between main PA or 
sleep outcomes (mean step count or sleep efficiency 
respectively), and patient characteristics (age, BMI, 
and Beighton score) and patient-reported outcomes, 
bivariate correlations using Pearson’s correlation for 
normal distributed data and Spearman for non-normal 
distributed data, were calculated. Afterwards, backward 
stepwise linear regression analysis was performed with 
the variables which had a significant association with the 
main PA or sleep variable [53]. Multicollinearity among 
the independent variables was checked by computing 
a variance inflation factor (VIF) of which values above 
2.5 were used to indicate a multicollinearity problem 
in the model. Adjusted R square was used to explain 




Participant characteristics are shown in Table 2. No 
significant differences in BMI, age, profession, education, 
and marital status were observed between groups. 
Beighton score and pain were significantly higher in the 
patient groups compared to the controls (all p<0.001). 
Significantly less participants in the patient groups were 
working or studying, when compared to the controls. 
Furthermore, about half of the patients were on sick leave 
versus none in the CTR group.
Physical activity and sleep
Physical activity and sleep data are shown in Table 
3. All participants wore the monitors for a mean of 6.9 
valid days with 848.4 minutes of wearing time, with 
no differences between groups. Mean daily step counts 
were significantly lower in the hEDS (mean difference 
-1813 steps, 95% CI -3137.6 to -489.2 steps, p=0.022) 
and G-HSD group (mean difference -1637 steps, 95% 
CI -2942.2 to -332.4 steps, p=0.039) compared to the 
CTR group, with no differences between the two patient 
groups. Total bed time had non-significant higher average 
values in the patient groups compared to the controls 
(hEDS: 529.9 min, G-HSD: 524.3 min, controls: 490.6 
min, p=0.082). Other PA variables and sleep parameters 
did not significantly differ between the groups. When 
comparing step counts with recommended values (i.e., 
7500 steps/day), both patient groups scored significantly 
lower (p≤0.001, 70% and 81% of the adults with hEDS 
and G-HSD respectively did not meet the recommended 
step count), whereas healthy controls did not significantly 
differ from the recommended values (p=0.277, 58% of 
the controls did not meet the recommended step count). 
Sleep efficiency was significantly higher (p≤0.003) 
compared to the recommended value (85%) in all three 
groups (80%, 83%, and 90% of the adults with hEDS, 
G-HSD, and controls respectively met the recommended 
sleep efficiency).
Patient-reported outcomes
Questionnaire data are shown in Table 4. All 
variables measured were significantly different between 
the controls and the two patient groups (all p<0.001), 
except for anxiety which only showed a tendency toward 
statistical significance across all three groups (p=0.051). 
Depression, fatigue, pain impact, kinesiophobia, 
sleepiness, and pain medication were significantly higher 
in both patient groups compared to controls (p≤0.023), 
while subjectively scored sleep quality and quality of 
life [physical health component summary score (PCS) 
and mental health component summary score (MCS)] 
were significantly lower (p≤0.003). No differences were 
observed between the hEDS and G-HSD group on any 
variable.
Relationship between main PA and sleep 
parameters, and participant character-
istics and patient-reported outcomes
Table 5 shows the correlations between step counts 
or sleep efficiency, and age, BMI, and patient-reported 
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Table 2: Participant characteristics
hEDS (n=20) G-HSD (n=23) CTR (n=32) P value
Age (years) 34.5 [24.0–52.0] 30.0 [23.0–41.0] 33.5 [22.3–42.3] 0.386
BMI (kg/m2) 24.1 [19.4–31.7] 26.2 [24.0–29.2] 23.8 [20.9–29.1] 0.258
GJH (Beighton/9) 6.0 [5.0–7.0] 6.0 [5.0–7.0] 1.0 [0.0–3.0] <0.001*
Painful body surface area (Margolis, %) 25.7 [20.9–31.1] 31.3 [11.8–50.1] 1.0 [0.0–3.7] <0.001*
Profession 0.338
 Homemaker 2 (10.5%) 3 (13%) 1 (3.2%)
 Physical worker 1 (5.3%) 3 (13%) 1 (3.2%)
 Employee (sedentary worker) 8 (42.1%) 10 (43.5%) 15 (48.4%)
 Liberal profession 2 (10.5%) 0 (0%) 0 (0%)
 Other 6 (31.6%) 7 (30.4%) 14 (45.2%)
Current working status <0.001*
 Student 3 (16.7%) 3 (14.3%) 9 (29%)
 Employed 4 (22.2%) 7 (33.3%) 20 (64.5%)
 Homemaker 2 (11.1%) 1 (4.8%) 2 (6.5%)
 Sick leave 9 (50%) 10 (47.6%) 0 (0%)
Education 0.223
 Lower secondary education 2 (10.5%) 1 (4.3%) 0 (0%)
 Higher secondary education 3 (15.8%) 7 (30.4%) 5 (16.1%)
 Higher education 14 (73.7%) 15 (65.2%) 26 (83.9%)
Marital status 0.528
 Single 8 (42.1%) 9 (39.1%) 13 (41.9%)
 Married 6 (31.6%) 7 (30.4%) 13 (41.9%)
 Divorced 2 (10.5%) 0 (0%) 1 (3.2%)
 Living together 3 (15.8%) 7 (30.4%) 4 (12.9%)
Data are shown as median [quartile 1–quartile 3] or frequencies (absolute number and %); BMI: Body mass index; GJH: generalized 
joint hypermobility; hEDS: hypermobile Ehlers–Danlos syndrome; G-HSD: generalized hypermobility spectrum disorder; CTR: 
control group; liberal profession: an occupation pursued in relation to an ideal of public service and requiring substantial mastery of 
complex skills in the liberal arts or sciences (includes lawyers, engineers, doctors, dentists, notaries, among others); lower secondary 
education: until 15y; higher secondary education: until 18y; higher education: >18y, *: P value < 0.05.
Table 3: Physical activity and sleep
hEDS G-HSD CTR P value
Physical activity (n=20) (n=21) (n=31)
 Wearing time (min) 842.2 ± 60.01 833.9 ± 104.27 862.8 ± 48.31 0.329
 Valid days (days/week) 6.9 ± 0.31 6.7 ± 0.88 6.9 ± 0.36 0.393
 Step counts (n/day) 5233.5 ± 2485.52 5409.6 ± 2193.27 7046.9± 2280.41 0.010*
 MVPA (min/day) 74.7 ± 30.95 80.5 ± 28.88 89.1 ± 26.98 0.207
 Moderate (min/day) 65.7 ± 27.16 71.5 ± 25.42 78.1 ± 23.83 0.228
 Vigorous (min/day) 7.2 ± 4.43 7.1 ± 4.19 8.7 ± 5.06 0.375
 Very vigorous (min/day) 1.9 ±1.12 1.9± 0.94 2.3 ± 2.01 0.498
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hEDS G-HSD CTR P value
Sleep (n=20) (n=23) (n=31)
 Sleep efficiency (%) 88.3 ± 4.23 88.5 ± 3.68 89.2 ± 4.16 0.700
 Number of awakenings 16.8 ± 6.20 17.4 ± 5.51 17.4 ± 5.77 0.921
 Latency (min) 8.8 ± 6.94 9.2 ± 6.75 6.9 ± 3.61 0.312
 TBT (min) 529.9 ± 86.57 524.3 ± 72.06 490.6 ± 42.49 0.082
 TST (min) 467.3 ± 86.62 463.3 ± 60.86 438.0 ± 38.02 0.193
 WASO (min) 53.8 ± 18.61 51.9 ± 21.59 45.7 ± 20.06 0.339
Data are shown as mean ± standard deviation. All variables are means calculated over seven days, except for number of valid days. 
hEDS: hypermobile Ehlers–Danlos syndrome; G-HSD: generalized hypermobility spectrum disorder; CTR: control group; n= number 
of participants; wearing time: time that the physical activity tracker was worn between 7:00 AM and 10:00 PM; valid days: number 
of valid days (≥8 hours of physical activity tracker wearing time); MVPA: moderate to vigorous physical activity; TBT: total bed time; 
TST: total sleep time; WASO: wake after sleep onset; *: P value < 0.05.
Table 4: Patient-reported outcome scores of participants
hEDS (n=20) G-HSD (n=23) CTR (n=32) P value
Anxiety (HADS/21)° 5.3 ± 3.38 6.4 ± 3.21 4.1 ± 3.73 0.051
Depression (HADS/21)° 6.6 ± 2.97 6.6 ± 3.57 2.6 ± 2.59 <0.001*
Fatigue (CIS/140)° 81.7 ± 13.64 90.5 ± 13.91 61.0 ± 24.58 <0.001*
Pain impact (MPI/30) 17.1 ± 2.80 17.0 ± 4.40 8.6 ± 3.24 <0.001*
Kinesiophobia (TAMPA/68) 39.3 ± 7.20 43.6 ± 8.31 29.0 ± 7.22 <0.001*
Subjective sleep (/18)° 9.5 ± 3.48 10.0 ± 2.89 6.5 ± 2.89 <0.001*
Sleepiness (ESS/24)° 11.4 ± 5.91 13.1 ± 4.88 6.6 ± 4.33 <0.001*
QoL PCS (SF36/400) 117.5 [63.8–145.0] 110.0 [65.0–202.5] 337.5 [281.3–367.5] <0.001*
QoL MCS (SF36/400) 252.6 [213.3–275] 229.7 [153.3–310.0] 336.0 [251.2–364.0] <0.001*
Pain medication (doses/day)° 0.9 [0.1–2.0] 0.3 [0.0–1.3] 0.0 [0.0–0.0] <0.001*
Normal distributed data are shown as mean ± standard deviation, non-normal distributed data as medians [quartile 1–quartile 3]. °: 
variables of which means calculated over seven days are shown; hEDS: hypermobile Ehlers–Danlos syndrome; G-HSD: generalized 
hypermobility spectrum disorder; CTR: control group; HADS: hospital anxiety and depression questionnaire; CIS: checklist individual 
strength; MPI: multidimensional pain inventory; TAMPA: tampa scale for kinesiophobia; ESS: Epworth sleep scale; QoL: quality of 
life; PCS: physical health component summary score; MCS: mental health component summary score; SF36: RAND 36-item health 
survey; *: P value < 0.05.
Table 5: Association between primary outcomes and clinical measures in hEDS and G-HSD
Step counts Sleep efficiency
hEDS (n=20) G-HSD (n=21) hEDS (n=20) G-HSD (n=23)
Age (years) –0.503* –0.309 0.087 –0.432*
BMI (kg/m2) –0.578* 0.080 0.134 –0.398
Beighton (/9) –0.231 0.092 0.098 –0.118
Sleepiness (ESS) 0.272 0.073 0.065 –0.155
Pain surface (Margolis) –0.023 –0.456* 0.111 –0.192
Anxiety (HADS) –0.146 0.116 –0.179 –0.172
Depression (HADS) –0.462* –0.136 0.054 –0.341
Fatigue (CIS) –0.110 –0.176 0.106 –0.012
Pain medication –0.198 –0.393 –0.239 –0.221
Subjective sleep –0.238 0.122 0.238 –0.194
Pain impact (MPI) –0.162 –0.476* 0.193 –0.099
Kinesiophobia –0.458* –0.003 –0.238 –0.042
Data shown are Pearson (for normal distributed data) and Spearman (for non-normal distributed data, i.e., pain surface and pain 
medication) correlation coefficients. hEDS: hypermobile Ehlers–Danlos syndrome; G-HSD: generalized hypermobility spectrum 
disorder; BMI: body mass index; ESS: Epworth sleep scale; HADS: hospital anxiety and depression questionnaire; CIS: checklist 
individual strength; MPI: multidimensional pain inventory; *: P value < 0.05.
Table 3: (Continued)
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outcomes in both patient groups. Moderate statistically 
significant inverse correlations were found between step 
counts and age, BMI, depression, and kinesiophobia in 
the hEDS group (p<0.05 for all). In the G-HSD group, 
moderate statistically significant inverse correlations 
were identified between step counts and pain surface 
and psychosocial pain impact (p=0.038 and p=0.029, 
respectively).
All outcomes with significant correlations with step 
counts were included in the backward stepwise regression 
analysis (see Supplementary Tables A1 and A2). No 
multicollinearity problems were identified (all VIF<2.5). 
Regression analysis showed that the variance in BMI and 
kinesiophobia [TAMPA scale for Kinesiophobia (TSK 
score)] significantly explained 52.6% of the variance in 
step counts in the hEDS group. In the G-HSD group, 
18.5% of the variance in step counts could be attributed to 
variance in pain impact [multidimensional pain inventory 
(MPI score)].
step count number compared to controls and compared 
to the recommended 7500 steps per day (“somewhat 
active”). This study could not show significant objective 
differences between the three groups regarding sleep 
parameters, although patients subjectively scored their 
sleep quality as impaired. Second, this study determined 
that patient characteristics (BMI and age) and symptoms 
of depression and kinesiophobia were inversely 
correlated with step count number in the hEDS group, of 
which BMI and kinesiophobia explained more than half 
of the variance in step counts. In the G-HSD group, pain 
factors (painful surface and pain impact) were inversely 
correlated with step count number, of which 18.5% of the 
variance could be attributed to variance in pain impact. 
No contributors for sleep could be identified in the 
patient groups.
Physical activity
This study showed that objectively measured PA is 
reduced in adults with hEDS and G-HSD, demonstrated 
by 75% of this population which did not meet the 
recommended 7500 steps and had lower daily step 
counts in comparison with controls. These results are 
in accordance with previous research using patient-
reported questionnaires, which identified lower habitual 
PA and level of sport activities and poor PA levels with 
50% of the patients being inactive. Furthermore, this is 
in line with the observed reduced ambulation, daily living 
and sport activities in hypermobile patient populations 
[5, 8–10, 54].
By contrast, we could not identify any differences 
in MVPA between the three groups. This is different 
from patients with rheumatoid arthritis (RA) and 
fibromyalgia, who show lower levels of MVPA 
compared to controls, although these pathologies are 
both chronic musculoskeletal disorders with several 
clinical similarities with hEDS and G-HSD [55, 56]. We 
could hypothesize that adults with hEDS and G-HSD 
avoid walking, whereas they still perform many other 
activities, including exercises and physiotherapy—in 
which hypermobile patients frequently engage with 
[57, 58]. However, to our knowledge, there are no other 
studies concerning objective PA measurements in adults 
with hEDS and G-HSD with which we can compare our 
results. Therefore, our hypothesis should be interpreted 
with caution.
The present study showed that age, BMI, symptoms 
of depression, and kinesiophobia were moderately 
associated with objectively measured PA (step counts) 
in individuals with hEDS. Similar to the general healthy 
population, age and BMI were inversely associated with 
PA [59, 60]. The inverse correlation between symptoms 
of depression and PA could be attributed to both 
psychological and physiological mechanisms such as 
increased levels of serotonin and dopamine, increased 
endorphin secretion, improved self-esteem and self-
Table A1: Backward stepwise regression analysis with step 
counts as the dependent variable in the hEDS group
Variables° B SE β t p
BMI (kg/m2) –219.84 58.82 –0.61 –3.74 0.002*
Kinesiophobia –181.37 54.40 –0.55 –3.33 0.004*
°Only significant correlates were included in the model, 
*significant when p<0.05, B = unstandardized coefficient, 
SE = standard error, β = standardized coefficient, BMI = body 
mass index.
Table A2: Backward stepwise regression analysis with step 
counts as the dependent variable in the G-HSD group
Variables° B SE b t p
Pain impact (MPI) –242.38 102.87 –0.48 –2.36 0.029*
°Only significant correlates were included in the model, 
*significant when p<0.05, B = unstandardized coefficient, 
SE = standard error, β = standardized coefficient.
Regarding sleep, no significant correlations were 
found, except for a significant negative correlation 
between sleep efficiency and age in G-HSD (r=-0.432, 
p=0.040). Therefore, no backward stepwise regression 
analysis was performed.
DISCUSSION
This was the first study that objectively evaluated 
PA and sleep measures in adults with hEDS and G-HSD 
diagnosed according to the most recent diagnostic criteria, 
in comparison with a matched healthy control group 
and recommended values. Moreover, this study also 
determined contributors to PA in these patient groups. 
The results indicate that hEDS and G-HSD patients had 
a significantly lowered PA level, demonstrated by a lower 
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efficacy, and distraction from stressful stimuli when 
increasing PA [61]. This study identified kinesiophobia 
as a contributor to the decreased PA levels seen in adults 
with hEDS, which has previously also been hypothesized 
by Rombaut et al. (2010) [5]. Decreased PA in adults with 
hEDS could partially be explained by the fear avoidance 
model, in which injuries or pain during daily activities 
takes on negative value and becomes a conditioning 
stimulus, resulting in avoidance of these activities [62].
In the G-HSD group, pain surface and (psychosocial) 
impact of pain were inversely related with PA (step 
counts). Furthermore, in these patients pain impact could 
be identified as a determinant for PA, implying that a 
higher psychosocial impact of pain resulted in lower daily 
step counts. This is in accordance with previous research 
in patient populations with RA and fibromyalgia, showing 
associations between higher reported pain and lower PA 
levels [20, 63, 64].
Consequently, we can suggest that individuals with 
hEDS and G-HSD have reduced step count numbers, 
which could partly be attributed to fear of having pain in 
the hEDS group, and to the impact of pain in the G-HSD 
group. Surprisingly, fatigue did not contribute to the 
reduced PA in patients with hEDS/G-HSD. Furthermore, 
it was unexpected that pain did not come up as a 
contributing factor to reduced PA in hEDS. However, 
our results should be interpreted with caution because 
correlations had moderate strength and only 18% of 
the variance of PA in G-HSD could be explained by the 
psychosocial impact of pain in the linear regression 
model.
Sleep
This study showed conflicting results regarding 
subjectively and objectively measured sleep parameters. 
Results of the questionnaires showed that patients 
perceive lower sleep quality and report feeling sleepier 
during the day. However, excessive sleepiness (ESS≥16) 
could not be identified [65]. Furthermore, objective 
measurements (accelerometry) did not show many 
significant differences between patients with hEDS/
G-HSD and controls. Whereas total bed time was on 
average 30 minutes higher per night in the patient groups 
compared to the control group, this difference did not meet 
statistical significance. Furthermore, sleep efficiency met 
the recommendations for good sleep quality (total sleep 
time/total bed time≥85%) and a recommended total 
sleep time of 7 hours or more each night was achieved, on 
average, in all groups [51, 66]. 
By contrast, previous research in subjects with EDS 
showed a higher prevalence of obstructive sleep apnea 
measured by polysomnography or respiratory polygraphy 
[14, 16, 18]. However, to our knowledge, no other studies 
concerning sleep measured by accelerometry in adults with 
hEDS and G-HSD have been performed with which we can 
compare our results. On the other hand, our subjective 
sleep results of impaired subjective sleep quality evaluated 
by questionnaires are in line with previous studies [7, 15, 
16, 19, 67]. We can conclude that, although individuals 
with hEDS and G-HSD perceive more fatigue and poor 
sleep quality, sleep might not be impaired in adults 
with hEDS and G-HSD based on objective parameters. 
This difference between objective and subjective results 
could be due to the fact that, when assessing sleep, the 
loss of consciousness during sleep makes it hard to self-
observe sleep behavior [51]. Furthermore, orthostatic 
intolerance in hypermobile adults could also explain 
the feeling of being more fatigued [68, 69]. Finally, the 
difference in subjective sleep outcomes between patients 
and controls could be partially explained by the higher 
anxiety and depression in these patient groups. However, 
these conclusions should be interpreted with caution as 
polysomnography remains the golden standard for sleep 
measurements and could additionally identify sleep 
disordered breathing. Moreover, for sleep measurements 
based on accelerometry, currently no normative adult 
values exist, which makes it difficult to interpret these 
results [70].
hEDS versus G-HSD
No differences in PA, sleep, and clinical symptoms 
(pain, pain medication, sleepiness, quality of life, 
kinesiophobia, anxiety, depression, and fatigue) were 
found between the two patient groups (hEDS and 
G-HSD). Although this study showed that determinants 
of PA in the two patient groups differ, both can be traced 
back to the consequences of their experienced pain. 
In accordance with Hakim et al. (2019), these findings 
demonstrate that hEDS and G-HSD share many similar 
symptoms and comorbidities [71]. As such, Copetti et 
al. (2019) have previously suggested that the distinction 
between hEDS and HSD based on the current nosology 
does not reflect differences in the severity of all symptoms 
and comorbidities [72]. Based on the symptom profile, it 
is therefore inaccurate to regard G-HSD as a less severe 
pathology than hEDS. Although these patient groups 
differ with respect to soft tissue fragility and skin issues, 
patients in both groups require an individually adjusted 
treatment plan for their symptoms and co morbidities 
[3].
Clinical implications
This study showed that individuals with hEDS and 
G-HSD take less steps on a daily basis and do not meet 
the recommended international criteria for daily physical 
activity. As there is an inverse relationship of daily 
steps with important health outcomes in the general 
population such as all-cause mortality and cardiovascular 
events, improving daily steps could have health benefits 
in these patient groups [52, 73]. Furthermore, physical 
activity such as walking is essential for bone health, 
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which has shown to be impaired in some individuals 
with hEDS/HSD [74]. Based on our data regarding 
determinants of PA, targeting fear-avoidance beliefs 
and pain in individuals with hEDS and G-HSD could 
be recommended [75]. Several treatments evaluating 
cognitive behavior therapy (CBT) and graded activity 
exposure have already shown evidence to improve fear-
avoidance beliefs in patients with fibromyalgia [76–78]. 
However, only one small cohort study has evaluated 
this treatment option in individuals with symptomatic 
hypermobility, demonstrating positive outcomes [79]. 
Therefore, future studies should focus on evaluating 
treatments incorporating CBT, graded activity exposure, 
and pain relief in individuals with hEDS and G-HSD.
Limitations and strengths
To the best of our knowledge, this is the first study 
objectively evaluating PA and sleep in hEDS and G-HSD 
according to the new diagnostic criteria. Moreover, 
this study evaluated differences in PA, sleep, and 
clinical features between these two patient groups 
and determined contributors to PA. However, some 
limitations have to be considered when interpreting 
these results. First, sedentary time and light physical 
activity could not be determined as no cut-offs exist for 
adults based on the vector magnitude (tri-axial counts). 
Second, objectively and subjectively measured sleep 
parameters were analyzed based on self-reported bed and 
wake time and with three non-validated sleep questions, 
respectively, which could compromise the accuracy 
of the sleep analyses. Finally, selection bias could be 
considered as our control group had relatively low 
activity levels. However, current research shows that 40–
50% of the healthy Belgian population are inactive and 
accelerometers are known to underestimate step count 
number [80–82]. Nevertheless, this underestimation did 
not affect the differences in step count between the three 
groups (hEDS, G-HSD, and controls).
CONCLUSION
This study objectively assessed PA and sleep in 
adults with hEDS/G-HSD. No differences in objectively 
measured sleep parameters were identified, although 
patients scored their sleep quality as impaired. 
Furthermore, our results demonstrated that adults with 
hEDS and G-HSD were less active and had lower step 
counts than healthy peers, which may be partially due 
to kinesiophobia and the impact of pain, respectively. 
Therefore, treatment focusing on fear-avoidance beliefs 
and pain relief has sound clinical reasoning to likely 
result in increased daily step counts, which may further 
benefit overall health in these hypermobile patients.
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